Baidu
map

2018 香港鸡蛋过敏患者疫苗接种共识

2018-10-02 香港医学相关专家组(统称) Hong Kong Med J. 2018 Oct;24(5):527-531.

鸡蛋过敏症患者接种疫苗一直令不少医患困扰,因为部份疫苗在生产过程中运用鸡蛋胚胎或鸡只细胞,而其中流感疫苗及麻疹腮腺炎德国痲疹水痘混合疫苗特别令人关注。不少人担心疫苗内蕴含的鸡蛋蛋白可能令鸡蛋过敏症患者产生实时严重过敏反应。不过,近年国际医学界更新了建议,并指出对鸡蛋过敏的患者都可安全接种上述两种疫苗。有见及此,香港过敏医学会和香港儿童免疫过敏及传染病学会总结多个国际指引,以期为本地医生提供建议。

中文标题:

2018 香港鸡蛋过敏患者疫苗接种共识

英文标题:

Hong Kong Institute of Allergy and Hong Kong Society for Paediatric Immunology Allergy & Infectious Diseases joint consensus statement 2018 on vaccination in egg-allergic patients.

发布日期:

2018-10-02

简要介绍:

鸡蛋过敏症患者接种疫苗一直令不少医患困扰,因为部份疫苗在生产过程中运用鸡蛋胚胎或鸡只细胞,而其中流感疫苗及麻疹腮腺炎德国痲疹水痘混合疫苗特别令人关注。不少人担心疫苗内蕴含的鸡蛋蛋白可能令鸡蛋过敏症患者产生实时严重过敏反应。不过,近年国际医学界更新了建议,并指出对鸡蛋过敏的患者都可安全接种上述两种疫苗。有见及此,香港过敏医学会和香港儿童免疫过敏及传染病学会总结多个国际指引,以期为本地医生提供建议。 

拓展指南:疫苗相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 香港鸡蛋过敏患者疫苗接种共识)] GetToolGuiderByIdResponse(projectId=1, id=f54181c00165a049, title=2018 香港鸡蛋过敏患者疫苗接种共识, enTitle=Hong Kong Institute of Allergy and Hong Kong Society for Paediatric Immunology Allergy & Infectious Diseases joint consensus statement 2018 on vaccination in egg-allergic patients., guiderFrom=Hong Kong Med J. 2018 Oct;24(5):527-531., authorId=null, author=, summary=鸡蛋过敏症患者接种疫苗一直令不少医患困扰,因为部份疫苗在生产过程中运用鸡蛋胚胎或鸡只细胞,而其中流感疫苗及麻疹腮腺炎德国痲疹水痘混合疫苗特别令人关注。不少人担心疫苗内蕴含的鸡蛋蛋白可能令鸡蛋过敏症患者产生实时严重过敏反应。不过,近年国际医学界更新了建议,并指出对鸡蛋过敏的患者都可安全接种上述两种疫苗。有见及此,香港过敏医学会和香港儿童免疫过敏及传染病学会总结多个国际指引,以期为本地医生提供建议。 , cover=, journalId=null, articlesId=null, associationId=1311, associationName=香港医学相关专家组(统称), associationIntro=, copyright=0, guiderPublishedTime=Tue Oct 02 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>鸡蛋过敏症患者接种疫苗一直令不少医患困扰,因为部份疫苗在生产过程中运用鸡蛋胚胎或鸡只细胞,而其中流感疫苗及麻疹腮腺炎德国痲疹水痘混合疫苗特别令人关注。不少人担心疫苗内蕴含的鸡蛋蛋白可能令鸡蛋过敏症患者产生实时严重过敏反应。不过,近年国际医学界更新了建议,并指出对鸡蛋过敏的患者都可安全接种上述两种疫苗。有见及此,香港过敏医学会和香港儿童免疫过敏及传染病学会总结多个国际指引,以期为本地医生提供建议。 </div> <div><br> </div> 拓展指南:<strong>与<font color=red>疫苗</font>相关指南:</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=b42ab1c00165350e" title="2018 ASRM委员会意见:女性不孕症患者疫苗接种建议" target=_blank>2018 ASRM委员会意见:女性不孕症患者疫苗接种建议</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=8d4651c001650604" title="中国流感疫苗预防接种技术指南(2018-2019)" target=_blank>中国流感疫苗预防接种技术指南(2018-2019)</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=1136b1c001631965" title="2018 ACIP建议:百日咳,破伤风和白喉的疫苗预防" target=_blank>2018 ACIP建议:百日咳,破伤风和白喉的疫苗预防</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=cf2551c0016293c8" title="2018 WHO意见书:狂犬病疫苗" target=_blank>2018 WHO意见书:狂犬病疫苗</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=3fad31c001593866" title="2017年WHO HPV疫苗立场文件的解读" target=_blank>2017年WHO HPV疫苗立场文件的解读</a></li> 更多信息请点击:<a href="//m.sandwebs.com/guideline/list.do?q=%E7%96%AB%E8%8B%97" target=_blank>有关疫苗更多指南</a></ul>, tagList=[TagDto(tagId=40609, tagName=鸡蛋过敏), TagDto(tagId=7819, tagName=疫苗接种)], categoryList=[CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6256, appHits=79, showAppHits=0, pcHits=4246, showPcHits=2441, likes=132, shares=1, comments=2, approvalStatus=1, publishedTime=Sun Oct 21 22:00:20 CST 2018, publishedTimeString=2018-10-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Oct 21 22:00:20 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 21:42:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 香港鸡蛋过敏患者疫苗接种共识)])
2018 香港鸡蛋过敏患者疫苗接种共识
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=908418, encodeId=47c5908418f3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Wed Dec 16 06:54:51 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810509, encodeId=8f7581050932, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFOd4BACyOqgEYpxd3VV4KdARIdIh8OetzXQES5XwuQrwsyLiauicpn5JuCsybDxt4Mrib82MCVgbTQ/132, createdBy=ee4b5329563, createdName=hjhww007, createdTime=Tue Aug 18 20:48:04 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2020-12-16 ms5000001146316601

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=908418, encodeId=47c5908418f3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Wed Dec 16 06:54:51 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810509, encodeId=8f7581050932, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFOd4BACyOqgEYpxd3VV4KdARIdIh8OetzXQES5XwuQrwsyLiauicpn5JuCsybDxt4Mrib82MCVgbTQ/132, createdBy=ee4b5329563, createdName=hjhww007, createdTime=Tue Aug 18 20:48:04 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2020-08-18 hjhww007

    学习学习

    0

Baidu
map
Baidu
map
Baidu
map